192 related articles for article (PubMed ID: 22207075)
1. EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin.
Vandjelovic N; Zhu H; Misra HP; Zimmerman RP; Jia Z; Li Y
Mol Cell Biochem; 2012 May; 364(1-2):71-7. PubMed ID: 22207075
[TBL] [Abstract][Full Text] [Related]
2. An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor.
Suzumura K; Yasuhara M; Tanaka K; Odawara A; Narita H; Suzuki T
Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):1010-2. PubMed ID: 10434403
[TBL] [Abstract][Full Text] [Related]
3. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.
Yamamoto A; Hoshi K; Ichihara K
Eur J Pharmacol; 1998 Nov; 361(1):143-9. PubMed ID: 9851551
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of fluvastatin against reactive oxygen species induced DNA damage and mutagenesis.
Imaeda A; Aoki T; Kondo Y; Hori M; Ogata M; Obayashi H; Hasegawa G; Nakamura N; Tokuda K; Nishino H; Yoshikawa T; Kondo M
Free Radic Res; 2001 Jan; 34(1):33-44. PubMed ID: 11234994
[TBL] [Abstract][Full Text] [Related]
5. Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells.
Imaeda A; Tanigawa T; Aoki T; Kondo Y; Nakamura N; Yoshikawa T
Free Radic Res; 2001 Dec; 35(6):789-801. PubMed ID: 11811530
[TBL] [Abstract][Full Text] [Related]
6. Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity.
Bandoh T; Sato EF; Mitani H; Nakashima A; Hoshi K; Inoue M
Biol Pharm Bull; 2003 Jun; 26(6):818-22. PubMed ID: 12808293
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans.
Nash JD; Burgess DS; Talbert RL
J Med Microbiol; 2002 Feb; 51(2):105-109. PubMed ID: 11863260
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.
Ongini E; Impagnatiello F; Bonazzi A; Guzzetta M; Govoni M; Monopoli A; Del Soldato P; Ignarro LJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8497-502. PubMed ID: 15173604
[TBL] [Abstract][Full Text] [Related]
9. Direct free radical scavenging effects of water-soluble HMG-CoA reductase inhibitors.
Umeda R; Takanari H; Ogata K; Matsumoto S; Kitano T; Ono K; Tokumaru O
J Clin Biochem Nutr; 2019 Jan; 64(1):20-26. PubMed ID: 30705508
[TBL] [Abstract][Full Text] [Related]
10. Direct effects of statins on the vascular wall.
Corsini A; Pazzucconi F; Arnaboldi L; Pfister P; Fumagalli R; Paoletti R; Sirtori CR
J Cardiovasc Pharmacol; 1998 May; 31(5):773-8. PubMed ID: 9593078
[TBL] [Abstract][Full Text] [Related]
11. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits.
Rikitake Y; Kawashima S; Takeshita S; Yamashita T; Azumi H; Yasuhara M; Nishi H; Inoue N; Yokoyama M
Atherosclerosis; 2001 Jan; 154(1):87-96. PubMed ID: 11137086
[TBL] [Abstract][Full Text] [Related]
12. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy.
Ogata Y; Takahashi M; Takeuchi K; Ueno S; Mano H; Ookawara S; Kobayashi E; Ikeda U; Shimada K
J Cardiovasc Pharmacol; 2002 Dec; 40(6):907-15. PubMed ID: 12451324
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of fluvastain and its metabolites on the formation of several reactive oxygen species.
Nakashima A; Ohtawa M; Iwasaki K; Wada M; Kuroda N; Nakashima K
Life Sci; 2001 Aug; 69(12):1381-9. PubMed ID: 11531162
[TBL] [Abstract][Full Text] [Related]
14. Antioxidative effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on peroxidation of phospholipid liposomes.
Yamamoto A; Ichihara K; Hoshi K
J Pharm Pharmacol; 2001 Feb; 53(2):227-32. PubMed ID: 11273020
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on nitric oxide-induced hydroxyl radical generation in the rat heart.
Obata T; Ebihara A; Yamanaka Y
Biochim Biophys Acta; 2001 Apr; 1536(1):55-63. PubMed ID: 11335104
[TBL] [Abstract][Full Text] [Related]
16. Spin trapping endogenous radicals in MC-1010 cells: evidence for hydroxyl radical and carbon-centered ascorbyl radical adducts.
Bernofsky C; Bandara BM
Mol Cell Biochem; 1995 Jul; 148(2):155-64. PubMed ID: 8594420
[TBL] [Abstract][Full Text] [Related]
17. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
18. Effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities.
Bełtowski J; Wójcicka G; Jamroz A
J Cardiovasc Pharmacol; 2004 Jan; 43(1):121-7. PubMed ID: 14668577
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Weitz-Schmidt G; Nishibori M
J Leukoc Biol; 2005 Mar; 77(3):400-7. PubMed ID: 15618295
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of fluvastatin on degradation of apolipoprotein B by a radical reaction in human plasma.
Aoki S; Ikeda K; Yamamura M; Kojo S
Biol Pharm Bull; 2001 Feb; 24(2):123-6. PubMed ID: 11217077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
